Zsolt Kasza

516 total citations
15 papers, 385 citations indexed

About

Zsolt Kasza is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Zsolt Kasza has authored 15 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Pharmacology. Recurrent topics in Zsolt Kasza's work include Inflammatory mediators and NSAID effects (5 papers), CRISPR and Genetic Engineering (3 papers) and T-cell and B-cell Immunology (3 papers). Zsolt Kasza is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), CRISPR and Genetic Engineering (3 papers) and T-cell and B-cell Immunology (3 papers). Zsolt Kasza collaborates with scholars based in Sweden, United States and Singapore. Zsolt Kasza's co-authors include Kathleen A. Martin, John Hwa, Scott Gleim, Kristina M. Fetalvero, Johan Kreuger, Dorothe Spillmann, Katarina Holmborn, Fredrik Wermeling, Karen Douville and Jeremiah Stitham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Bioinformatics.

In The Last Decade

Zsolt Kasza

15 papers receiving 375 citations

Peers

Countries citing papers authored by Zsolt Kasza

Since Specialization

Citations

This map shows the geographic impact of Zsolt Kasza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zsolt Kasza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zsolt Kasza more than expected).

Fields of papers citing papers by Zsolt Kasza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zsolt Kasza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zsolt Kasza. The network helps show where Zsolt Kasza may publish in the future.

Co-authorship network of co-authors of Zsolt Kasza

This figure shows the co-authorship network connecting the top 25 collaborators of Zsolt Kasza. A scholar is included among the top collaborators of Zsolt Kasza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zsolt Kasza. Zsolt Kasza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2 2022 ·Journal of Autoimmunity ·(unknown), (unknown), Anna‐Karin Johnsson, Bruno Raposo, Ravi Sharma, (unknown), Zsolt Kasza, Kah Wai Lim, Karine Chemin, Gunnar Nilsson, Vivianne Malmström, Anh Tuân Phan, Fredrik Wermeling	9
2	In vitro and ex vivo functional characterization of human HLA-DRB1∗04 restricted T cell receptors 2021 ·Journal of Translational Autoimmunity ·(unknown), Ravi Sharma, Anatoly Dubnovitsky, Bruno Raposo, Christina Gerstner, (unknown), (unknown), Zsolt Kasza, William W. Kwok, Aaron Winkler, Lars Klareskog, Vivianne Malmström, Maria Bettini, Fredrik Wermeling	7
3	A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic system 2021 ·Computational and Structural Biotechnology Journal ·(unknown), Long Jiang, (unknown), Bruno Raposo, Anatoly Dubnovitsky, (unknown), Zsolt Kasza, Fredrik Wermeling	2
4	Designing custom CRISPR libraries for hypothesis-driven drug target discovery 2020 ·Computational and Structural Biotechnology Journal ·(unknown), Long Jiang, (unknown), (unknown), Sudeepta Kumar Panda, Zsolt Kasza, Bernhard Schmierer, Fredrik Wermeling	12
5	IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints 2020 ·Proceedings of the National Academy of Sciences ·Sudeepta Kumar Panda, Gustaf Wigerblad, Long Jiang, (unknown), (unknown), (unknown), (unknown), André Ortlieb Guerreiro‐Cacais, Bruno Raposo, Zsolt Kasza, Fredrik Wermeling	27
6	Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus – distinct roles of BAFF and APRIL 2018 ·Lupus ·Ioannis Parodis, (unknown), Francesca Faustini, Zsolt Kasza, (unknown), Agneta Zickert, Elisabet Svenungsson, Ronald van Vollenhoven, Vivianne Malmström, Fredrik Wermeling, Iva Gunnarsson	26
7	Green listed—a CRISPR screen tool 2016 ·Bioinformatics ·Sudeepta Kumar Panda, (unknown), (unknown), Long Jiang, Zsolt Kasza, (unknown), Fredrik Wermeling	5
8	MicroRNA-24 Suppression of N-Deacetylase/N-Sulfotransferase-1 (NDST1) Reduces Endothelial Cell Responsiveness to Vascular Endothelial Growth Factor A (VEGFA) 2013 ·Journal of Biological Chemistry ·Zsolt Kasza, Peder Fredlund Fuchs, Christoffer Tamm, Anna Eriksson, P.W. O’Callaghan, Femke Heindryckx, Dorothe Spillmann, Erik Larsson, Sébastien Le Jan, Inger Eriksson, Pär Gerwins, Lena Kjellén, Johan Kreuger	24
9	On the Roles and Regulation of Chondroitin Sulfate and Heparan Sulfate in Zebrafish Pharyngeal Cartilage Morphogenesis 2012 ·Journal of Biological Chemistry ·Katarina Holmborn, (unknown), Zsolt Kasza, Anna Eriksson, (unknown), Sandeep Gopal, John Couchman, Per Ahlberg, Małgorzata Wiweger, Dorothe Spillmann, Johan Kreuger, Johan Ledin	50
10	Functional Overlap Between Chondroitin and Heparan Sulfate Proteoglycans During VEGF-Induced Sprouting Angiogenesis 2012 ·Arteriosclerosis Thrombosis and Vascular Biology ·Sébastien Le Jan, Makoto Hayashi, Zsolt Kasza, Inger Eriksson, Joseph R. Bishop, Irene Weibrecht, Johan Heldin, Katarina Holmborn, Lars Jakobsson, Ola Söderberg, Dorothe Spillmann, Jeffrey D. Esko, Lena Claesson‐Welsh, Lena Kjellén, Johan Kreuger	52
11	Comprehensive Biochemical Analysis of Rare Prostacyclin Receptor Variants 2010 ·Journal of Biological Chemistry ·Jeremiah Stitham, Eric Arehart, (unknown), Scott Gleim, Karen Douville, Zsolt Kasza, Kristina M. Fetalvero, Todd A. MacKenzie, John F. Robb, Kathleen A. Martin, John Hwa	19
12	Novel signaling pathways promote a paracrine wave of prostacyclin-induced vascular smooth muscle differentiation 2009 ·Journal of Molecular and Cellular Cardiology ·Zsolt Kasza, Kristina M. Fetalvero, Min Ding, Róbert Wágner, Klára Ács, Anthony K. Guzman, Karen Douville, Richard J. Powell, John Hwa, Kathleen A. Martin	14
13	Prostacyclin receptor/thromboxane receptor interactions and cellular responses in human atherothrombotic disease 2009 ·Current Atherosclerosis Reports ·Scott Gleim, Zsolt Kasza, Kathleen A. Martin, John Hwa	19
14	Acceleration of Cardiovascular Disease by a Dysfunctional Prostacyclin Receptor Mutation 2008 ·Circulation Research ·Eric Arehart, Jeremiah Stitham, Folkert W. Asselbergs, Karen Douville, Todd A. MacKenzie, Kristina M. Fetalvero, Scott Gleim, Zsolt Kasza, (unknown), (unknown), (unknown), John F. Robb, Aaron V. Kaplan, Michael Simons, Richard J. Powell, Jason H. Moore, Eric B. Rimm, Kathleen A. Martin, John Hwa	94
15	Prostacyclin, Atherothrombosis, and Cardiovascular Disease 2007 ·Current Medicinal Chemistry ·(unknown), Scott Gleim, Zsolt Kasza, Kristina M. Fetalvero, Kathleen A. Martin, John Hwa	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact